Biocompatibility of hemodialysis membranes: Interrelations between plasma complement and cytokine levels

Blood Purification

Volumn 19, Issue 4, 2001, Pages 370-379

  Varela, Maria P ^a   Kimmel, Paul L ^a   Phillips, Terry M ^a   Mishkin, Gary J ^a   Lew, Susie Q ^a   Bosch, Juan P ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

C3a; C5a; Chronic renal diseases; Complement; Hemodialysis; Interleukin 1; Interleukin 2

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; CUPROPHANE; INTERLEUKIN 1; INTERLEUKIN 2;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; BLOOD ANALYSIS; BODY TEMPERATURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIALYSIS MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; CELLULOSE; COMPLEMENT C3A; COMPLEMENT C5A; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-1; INTERLEUKIN-2; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; RENAL DIALYSIS; TEMPERATURE;

EID: 0035742643     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046967     Document Type: Article

References (49)

1. Definition of biocompatibility
2. Biocompatibility of hemodialysis membranes
3. Hemodialysis associated platelet activation and thrombocytopenia
4. Dialysis membrane biocompatibility
5. Novel C5-dependent mechanism of neutrophil stimulation by bioincompatible dialyzer membranes
6. Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes
7. First-use syndrome with cuprammonium cellulose dialyzers
8. Complement activation and hypersensibility reactions to dialysis membranes
9. Membrane biocompatibility
10. Choice of the hemodialysis membrane
11. Hemodialysis hypotension: The interleukin hypothesis
12. Interleukin-1 and its relevance in patients treated with hemodialysis
13. Effect of renal replacement therapy on cellular cytokine production in patients with renal disease
14. Imunologic function and survival in hemodialysis patients
15. Human interleukin-1 production during hemodialysis
16. Cuprammonium membranes stimulate interleukin-1 release and arachidonic acid metabolism in monocytes in the absence of complement
17. Plasma interleukin-1 activity during HD: The influence of dialysis membranes
18. Blood-membrane interaction in hemodialysis leads to increased cytokine production
19. Hemofiltration and double high flux dialysis: Risks and benefits
20. Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISA with monoclonal antibodies
21. Chemiluminescent enzyme immunoassay of α-fetoprotein based on an adamantyl dioxetane phenyl phosphate substrate
22. Effect of the dialysis membrane on mortality of chronic hemodialysis patients
23. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor
24. In vivo induction of interleukin-1 during hemodialysis
25. Activation of the alternative pathway of complement by hemodialysis membranes
26. Rapid activation of the complement system by cuprophane depends on complement component C4
27. Complement activation by biomaterials
28. Polyethylene-glycol chain (PEG chain) grafted cellulosic membrane: Characterization of clinical biocompatibility and mechanism of biocompatibility
29. Reversal of hemodialysis granulocytopenia and pulmonary leukostasis
30. Compartmental distribution of complement activation products in artificial kidneys
31. Symptoms and activation of granulocytes and complement with two dialysis membranes
32. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes
33. Studies of biocompatibility of different dialyzer membranes: Role of complement system, intracellular calcium and inositol-triphosphate
34. A clinical study on different cellulosic dialysis membranes
35. Fluid phase generation of terminal complement complex as a novel index of bioincompatibility
36. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement
37. Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxins (LPS)
38. Enhancement of in vitro human interleukin-1 production by sodium acetate
39. Zinc modulates mononuclear cellular calcitriol metabolism in peritoneal dialysis patients
40. Cytokines: Agents provocateurs in hemodialysis?
41. C3a (C3adesArg) induces production and release of interleukin 1 by cultured human monocytes
42. Hemofiltration and hemodiafiltration
43. Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis
44. The role of dialysate in the stimulation of interleukin-1 production during clinical hemodialysis
45. Altered interleukin-1 production in patients undergoing hemodialysis
46. Current concepts. Lymphokines
47. Fever
48. In vivo T cell preactivation in chronic uremic hemodialyzed and nonhemodialyzed patients